Stock Ticker

  • Loading stock data...

Mallinckrodt PLC (NYSE:MNK) Pays $5.8 billion To Acquire Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Boston, MA 08/19/2014 (wallstreetpr) –According to recent reports, Mallinckrodt PLC (NYSE:MNK) has decided to acquire Questcor Pharmaceuticals Inc (NASDAQ:QCOR). The deal has been valued at approximate $5.8 billion. The shares of MNK surged as soon as this news came out. MNK To Join S&P 500 Club: The shares of the company inclined by 1.1% after […]

In A $5.6 Billion Deal, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) Get Past Major Hurdle

Boston, MA 05/21/2014 (wallstreetpr) – The drug maker Questcor Pharmaceuticals Inc (NASDAQ:QCOR) just got over a major hurdle in its efforts to merge into a fellow drug company. The U.S. Federal Trade Commission announced the termination of the antitrust review of the deal between Questcor and Mallinckrodt PLC (NYSE:MNK). The development gives the companies an […]

Mallinckrodt PLC (NYSE:MNK)’s Ofirmev Price Hike Looks Positive To Analysts

Boston, MA 05/21/2014 (wallstreetpr) – Mallinckrodt PLC (NYSE:MNK)‘s decision to raise price of its Ofirmev led research firms to revise their rating for the stock upward. The revision has indeed helped the company to record gains in its last trading session, where it inched up nearly 2%. UBS Raises Price Target The first rating upgrade […]

Start Due Diligence Here: Mallinckrodt PLC (NYSE:MNK), Targa Resources Partners LP (NYSE:NGLS), LyondellBasell Industries NV (NYSE:LYB)

Boston, MA 05/20/2014 (wallstreetpr) – The proposed tie-up of Mallinckrodt PLC (NYSE:MNK) and Questcor Pharmaceuticals Inc (NASDAQ:QCOR) just got over a major hurdle following the U.S. Antitrust approval of the deal, quicker than usual. That marks an important milestone for the two specialty pharmaceuticals that seek to join forces to take advantage of their respective strengths […]

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) Enters Into An Agreement With Mallinckrodt PLC (NYSE:MNK)

Boston, MA 04/10/2014 (wallstreetpr) – Questcor Pharmaceuticals Inc (NASDAQ:QCOR) along with Mallinckrodt PLC (NYSE:MNK) made an announcement on April 7, 2014 that the two firms have signed a definite merger agreement with each other. According to this agreement MNK will be acquiring QCOR through a transaction worth up to $5.6 billion. This transaction has already been […]

Cadence Pharmaceuticals Inc (NASDAQ:CADX)’s Drug Ofirmev Attracts Mallinckrodt Plc (NYSE:MNK) To Overtake It

Boston, MA 02/12/2014 (wallstreetpr) – Cadence Pharmaceuticals Inc (NASDAQ:CADX) is reportedly to be overtaken by Mallinckrodt Plc (NYSE:MNK) in a cash deal of around $1.3 billion. Mallinckrodt is offering Cadence 26% above the San Diego based company’s shares’ closing price in New York on Feb 11 which means $14 per share. Expand specialty pharmaceuticals business […]

Sign Up To Get Our Latest Stocks Alerts